apoA-IV Antibodies

Santa Cruz Biotechnology provides a broad selection of apoA-IV monoclonal antibodies for research focused on understanding apolipoprotein A-IV in lipid metabolism and cardiovascular health. ApoA-IV monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein A-IV is a key component involved in the transport and metabolism of lipids, playing a crucial role in the regulation of cholesterol levels and the prevention of atherosclerosis. The role of apolipoprotein A-IV extends to the modulation of appetite and energy expenditure, making it a significant factor in metabolic disorders. Research on apolipoprotein A-IV continues to reveal new insights into the mechanisms underlying cardiovascular diseases and obesity. Understanding apolipoprotein A-IV function has become increasingly important in developing therapeutic strategies for metabolic and cardiovascular conditions. Investigating apolipoprotein A-IV pathways can lead to breakthroughs in treating obesity-related disorders and heart disease. Santa Cruz Biotechnology monoclonal antibodies for apolipoprotein A-IV research support scientists worldwide in advancing our understanding of cardiovascular and metabolic health.